- Home
- Companies
- north america
- cannabinoids
Show results for
Refine by
Cannabinoids Suppliers In North America
23 companies found
based inMonmouth Junction, NEW JERSEY (USA)
MedChemExpress (MCE) offers a wide range of high-quality research chemicals and biochemicals (novel life-science reagents, reference compounds and natural compounds) for scientific use. We have professionally experienced and friendly staff to meet ...
Tropisetron Hydrochloride (SDZ-ICS-930) is an effective neuroprotective agent that acts as a 5-HT3 receptor antagonist, a calmodulin inhibitor, and an α7-nAChRreceptor agonist, with an IC50 of 70.1 nM for the 5-HT3 receptor. Tropisetron ...
based inGreensboro, NORTH CAROLINA (USA)
Founded in 1994 by entrepreneur and innovator Phil Shugart and led by him today, Carolina Liquid Chemistries Corp. is a leading provider of chemistry instruments and reagents for use in reference laboratories and clinical laboratories located in ...
The EasyRA benchtop analyzer is a fully automated clinical chemistry analyzer that accommodates the diverse needs of small to mid-sized laboratories and is well suited for urine drug screening and general ...
based inToronto, ONTARIO (CANADA)
Avicanna is a Canadian biopharmaceutical company providing the global marketplace with advanced natural cannabinoid solutions through an evidence-based approach offered across several product platforms including API, medical, pharmaceutical, and ...
based inSan Francisco, CALIFORNIA (USA)
Family owned and operated since 1943, Anresco Laboratories provides comprehensive analytical testing services to the food and food-related industries. We are an ISO/IEC 17025:2005 accredited laboratory and recognized by the United States Food and ...
Cannabinoids are the naturally occurring chemical compounds found in cannabis that work together to produce varying psychoactive and non-psychoactive effects. In combination, they are known to act synergistically to form an ...
based inJupiter, FLORIDA (USA)
Dyadic International, Inc. (NASDAQ: DYAI) is a global biotechnology company focused on building innovative microbial platforms to address the growing demand for global protein bioproduction and unmet clinical needs for effective, affordable, and ...
Reducing the cost of recombinant protein production requires a highly productive, low-cost expression system with commercial scale flexibility. We are actively applying our proprietary Dapibus™ platform and other technologies to address this ...
based inVancouver, BRITISH COLUMBIA (CANADA)
InMed Pharmaceuticals is a global leader in the pharmaceutical research, development and manufacturing of rare cannabinoids and cannabinoid analogs, including clinical and preclinical programs targeting the treatment of diseases with high unmet ...
INM-088 is a topical eye drop formulation under development for the treatment of glaucoma. The active pharmaceutical ingredient (API) in INM-088 is cannabinol, also known as CBN, a rare cannabinoid showing promise in its potential ...
based inDavis, CALIFORNIA (USA)
Arcadia Biosciences is a global leader in designing crops to meet the needs of a hungry population in a resource restricted world. Our innovations bring new value to formerly commoditized crops through functional nutritional benefits like added ...
based inSan Diego, CALIFORNIA (USA)
SwabTek’s novel test kits set a new standard for narcotics and explosives presumptive field-testing, with technology that is simple, safe, and effective. SwabTek’s dry, paper-based tests provide a safe and simple solution to put field test kits back ...
SwabTek’s Cannabis Test Kit is the answer for testing for the presumptive presence of cannabis in an age where cannabis products are available in any form. Since the kit uses a treated cotton swab, it can be used to test for cannabis residue ...
based inMontreal, QUEBEC (CANADA)
As a specialty therapeutics, clinical-stage biotech company, Inversago Pharma develops new generations of peripherally-acting cannabinoid-1 receptor (CB1) inverse agonists for the treatment of diabetic kidney disease, type 1 and type 2 diabetes, ...
It is involved in regulating several pathways linked to energy intake, reserves and overall expenditure. To do so, the cannabinoid-1 receptor (CB1) may be activated and deactivated such that it impacts many metabolic pathways ...
based inDoylestown, PENNSYLVANIA (USA)
Diverse Biotech, Inc is an innovative drug-discovery & biopharmaceutical research company committed to discovering and developing novel therapies from its proprietary conjugate drug synthesis Platform. The company originated from oncologists adding ...
based inDallas, TEXAS (USA)
Santa Cruz Biotechnology is a world leader in the development of products for the biomedical research market. Over the past thirty years, Santa Cruz Biotechnology has focused on the ongoing development of research monoclonal antibodies, ...
Olivetolic Acid is a key metabolic intermediate in the biosynthesis of ...
based inNaples, FLORIDA (USA)
Enveric Biosciences is leveraging its discovery engine and intellectual property portfolio to identify and build the next generation of psychedelic and cannabinoid medicines for the mind and body. By harnessing the power of synthetic biology and ...
Radiodermatitis (also called radiation dermatitis) is a skin condition caused by the high-energy X-rays delivered during radiation therapy. It affects nearly 95% of patients who receive radiation for cancer treatment, with approximately 85% of ...
based inMississauga, ONTARIO (CANADA)
Award-winning, Clinical Stage/Life-Sciences company focused on the drug discovery and development of next-generation targeted therapeutics within the endocannabinoid system and specific brain receptors. The company is targeting anxiety, depression, ...
There are three major parts to the system, enzymes, receptors, and endocannabinoids. The body makes these molecules. Endocannabinoids are similar to cannabinoids, such as CBD. Researchers have isolated two critical endocannabinoids, ...
based inVancouver, BRITISH COLUMBIA (CANADA)
We’re a leading bioscience company focused on accelerating new and innovative medical solutions for positive impact. XPhyto is striving to have a positive impact on global health. We are creating potentially life-changing solutions through research, ...
based inNorth Perth, AUSTRALIA
Botanix Pharmaceuticals is a clinical stage synthetic cannabinoid pharmaceutical company with a targeted pipeline of dermatology and antimicrobial products. We have attracted a world-class team and significant capital to support the progression of ...
BTX 1801 is initially focused on preventing surgical site infections (SSIs), which are caused by bacteria that get in through surgery incisions and threaten millions of lives every year. Botanix plans to test the capabilities of synthetic ...
based inWaltham, MASSACHUSETTS (USA)
Thermo Fisher Scientific Inc. (NYSE: TMO) is the world leader in serving science, with annual revenue exceeding $25 billion. Our Mission is to enable our customers to make the world healthier, cleaner and safer. Whether our customers are ...
based inArlington Heights, ILLINOIS (USA)
Automatic Liquid Packaging Solutions, LLC specializes in providing advanced liquid packaging solutions tailored to meet the needs of various industries. Located in Arlington Heights, Illinois, their facility offers a comprehensive range of equipment ...
ALPS can be The Right Fit © for your company and its non-aseptic Contract Packaging applications. We take pride in providing R&D services for unique container design and mechanical stability studies of liquid products in various aseptic and ...
based inDenver, COLORADO (USA)
Nexien BioPharma is proceeding with pre-clinical and clinical drug development activities, in accordance with U.S. Food and Drug Administration ('FDA') protocols, for a number of pharmaceutical formulations that include cannabinoids. Nexien ...
Nexien BioPharma is proceeding with pre-clinical and clinical drug development activities, in accordance with U.S. Food and Drug Administration ("FDA") protocols, for a number of pharmaceutical formulations that include ...
based inNew York, NEW YORK (USA)
We are a biopharmaceutical company developing transformational therapeutics targeting serious diseases with significant unmet medical needs. Our mission is to improve patient outcomes and save lives. To achieve our mission, we seek to capitalize on ...
We are developing MRI-1867, our licensed rationally designed, orally available, dual-action, hybrid, small molecule that is an inverse agonist of the CB1 receptor, as well as an inhibitor of the iNOS ...
based inColumbia, MARYLAND (USA)
Shimadzu Scientific Instruments (SSI) is the American subsidiary of Shimadzu Corporation, headquartered in Kyoto, Japan. Shimadzu is a $3 billion multinational corporation with three major divisions: Medical Diagnostics, Aerospace/industrial, and ...